aTyr Pharma, Inc. (LIFE) – Full Trading Performance Analysis

Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of aTyr Pharma, Inc. (LIFE) was $0.39. Currently, the 1st Resistance Point for this stock is $0.41, with a 2nd Resistance Point sitting at $0.42. Meanwhile, this company’s stock has a 1st Support Level at $0.37 and a 2nd Support Level at $0.34. aTyr Pharma, Inc. (LIFE) stock has gained 0.10%, in the past five days. In the last full month, these shares have lost -$0.14, or -26.55%. In the past three months, this stock’s price has fallen by -$0.07, or -14.44%. This year-to-date, aTyr Pharma, Inc. (LIFE) shares have lost -$0.11, or -21.37%.

Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For aTyr Pharma, Inc. (LIFE) stock, 60% of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 25% of medium-term indicators point to this stock being a “ Sell .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Sell .”

With 45,868 K shares outstanding, this company currently has a market capitalization of $17,425K. aTyr Pharma, Inc. (LIFE) generates annual net income of -$34,520 K. This stock has generated a 1-Year Total Return of -59.38%, a 3-Year Total Return of -86.07%, and a 5-year Total Return of 0.00%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.

In the most recently-reported fiscal quarter, which ended in Mar-19, aTyr Pharma, Inc. (LIFE) reported earnings of -$0.18 per share. Wall Street analysts, on average, were expecting the company to report earnings of -$0.23 per share, representing a 0.05 difference and -20.35% surprise. In the previous quarter ending in Dec-18, the reported earnings of -$0.21 represented a 0.01 difference from the consensus estimate calling for -$0.22 per share, which was a -3.23% surprise.

In the year-ago quarter, aTyr Pharma, Inc. (LIFE) generated per-share earnings of -$0.35. If the analysts are correct about the current quarter’s earnings, the growth will be +285,528.57% .

Turning our focus now to insider trading activity, there have been 1 purchases (12,500 shares in total) and 1 sale (4,651 shares in total) in the last 3 months. In the last 6 months, there have been 3 insider buys amounting to 257,500 shares and 1 insider sales amounting to 4,651 shares. In the past full year, 11 insider purchases were made (involving 701,885 shares) and 1 insider sell-offs equivalent to 4,651 shares.

Moving onto liquidity, aTyr Pharma, Inc. (LIFE) has a Current Ratio of 4.69, a Quick Ratio of 4.69 and a Cash Ratio of 4.57. Looking at this company’s capital structure, its Total Debt to Total Equity is 47.64, its Total Debt to Total Capital is 32.27, and its Total Debt to Total Assets is now 30.39. Looking even further ahead into the future, its Long-Term Debt to Equity is 24.56 and its Long-Term Debt to Total Capital is 16.63.